Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Goodwill

The latest goodwill for 600332.SS is $920M as of June 2026. That compares with $830M in the prior-year period — up 10.3% year over year. Investors often review this figure alongside Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 600332.SS's goodwill moved from $830M to $920M — a 10.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's operating scale or balance-sheet position.

A goodwill figure of $920M for 600332.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 600332.SS's goodwill ($920M), review year-over-year change from $830M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.